IDO1 and neoplasm: The induction of indoleamine-pyrrole 2,3 dioxygenase (IDO-1) on both myeloid and tumor cells results in decreased levels of tryptophan and the presence of immunosuppressive catabolites such as kynurenine (Kyn) that promote Treg activity and diminish T cell effector function [42,43,44].